Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2012
10/25/2012US20120270802 Binding molecules for the treatment of myeloid cell malignancies
10/25/2012US20120270792 Urocortin-iii and uses thereof
10/25/2012US20120270781 Expression Vectors and Cell Lines Expressing Vascular Endothelial Growth Factor D, and Method of Treating Melanomas
10/25/2012US20120270773 Trim5alpha mutants and uses thereof
10/25/2012US20120270265 Methods of obtaining a specific binding member that binds eotaxin
10/25/2012US20120270254 Method for analyzing secretome, biomarker for lung cancer metastasis, and sirna compound for inhibiting lung cancer metastasis
10/25/2012US20120270219 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
10/25/2012US20120270208 Synthetic antigens for the detection of antibodies to hepatitis c virus
10/25/2012US20120270202 Pre-Transplant Accommodated Organs Resistant To Anti-Donor Immunity
10/25/2012US20120269858 Polypeptides
10/25/2012US20120269843 S. epidermidis antigens
10/25/2012US20120269838 Carrier conjugates of il-23-peptides and their induced antibodies
10/25/2012US20120269837 SUBSTANCE BINDING HUMAN IgG Fc RECEPTOR IIb (FcgammaRIIb)
10/25/2012US20120269831 Substituted pyrido[2,3-d]pyrimidin-7(8h)-ones and therapeutic uses thereof
10/25/2012US20120269830 Conjugates with improved pharmacokinetic properties
10/25/2012US20120269824 Therapeutic human anti-il-1r1 monoclonal antibody
10/25/2012US20120269823 Virulent isolate of neospora caninum and its uses
10/25/2012US20120269822 Anti-Botulinum Neurotoxin a Single Domain Antibody Antibodies
10/25/2012US20120269821 Hiv-1 antibodies
10/25/2012US20120269820 Anti-il 17a/il-17f cross-reactive antibodies and methods of use thereof
10/25/2012US20120269819 Human Anti-IFN-gamma Neutralizing Antibodies as Selective IFN-gamma Pathway Inhibitors
10/25/2012US20120269817 Monoclonal Antibodies Against Tissue Factor Pathway Inhibitor
10/25/2012US20120269815 Neurotrophins and uses thereof
10/25/2012US20120269814 Anti-c mpl antibodies
10/25/2012US20120269812 Monospecific and bispecific anti-igf-1r and anti-erbb3 antibodies
10/25/2012US20120269811 Humanized fc gamma riib-specific antibodies and methods of use thereof
10/25/2012US20120269801 Methods and compositions for the treatment of proliferative and pathogenic diseases
10/25/2012US20120269799 Diagnostic and treatment methods using a ligand library
10/25/2012US20120269765 Cytokine compositions and methods of use thereof
10/25/2012US20120269764 RBM3 as a Marker for Malignant Melanoma Prognosis
10/25/2012US20120269731 Polypeptides that home to atherosclerotic plaque
10/25/2012US20120269729 Stabilized chitosan-based nanoparticles and methods for making the same
10/25/2012US20120269723 Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent
10/25/2012US20120269720 Detection of hepatic insulin resistance
10/25/2012DE102008049136B4 Neue Regulatoren des angeborenen Immunsystems New regulators of the innate immune system
10/24/2012EP2515115A2 Kit for diagnosing prostate cancer and diagnosis method
10/24/2012EP2515110A1 Fluoroimmunoassay method
10/24/2012EP2514837A1 Markers for brain damage
10/24/2012EP2514824A2 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
10/24/2012EP2514823A2 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
10/24/2012EP2514821A1 Cystatin c, beta2 microglobulin, alpha1 microglobulin and genes for same, antibody, and kit and method for diagnosis of feline nephropathy
10/24/2012EP2514767A1 Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders
10/24/2012EP2514766A2 Antibodies, methods and kits for diagnosing and treating melanoma
10/24/2012EP2514765A1 Gpr177 as target and marker in tumors
10/24/2012EP2514764A2 Antibody molecules which bind IL-17A and IL-17F
10/24/2012EP2514763A1 Egf receptor epitope peptides and uses thereof
10/24/2012EP2514439A1 Anti-TSG101antibodies and their uses for treatment of viral infections
10/24/2012EP2513308A1 Modulation of pilr to treat immune disorders
10/24/2012EP2513293A1 Method for optimizing a biopharmaceutical production process
10/24/2012EP2513148A1 Anti-her2 antibodies and their uses
10/24/2012EP2513147A2 Novel antagonist antibodies and their fab fragments against gpvi and uses thereof
10/24/2012EP2513146A2 Biological inhibitors of ror1 capable of inducing cell death
10/24/2012EP2513145A1 Single variable domain antibodies against ox40l, constructs and therapeutic use
10/24/2012EP2513144A1 Methods of treating interstitial cystitis
10/24/2012EP2513143A1 Antibodies directed against the transferrin receptor and uses thereof for immunotherapy of iron-dependent tumours
10/24/2012EP2513142A1 Membranes and associated methods for purification of antibodies
10/24/2012EP2513134A1 Wash solution and method for affinity chromatography
10/24/2012EP2512600A2 Wise binding agents and epitopes
10/24/2012EP2512511A1 Humanized antibodies against human il-22ra
10/24/2012CN102753581A Antl-igf-ir antibodies and uses thereof
10/24/2012CN102753580A Anti-egfr antibodies and their uses
10/24/2012CN102753579A Anti-cadherin antibody
10/24/2012CN102753578A Compositions and methods for increasing muscle growth
10/24/2012CN102753577A Bispecific anti-vegf/anti-ang-2 antibodies
10/24/2012CN102753199A Cancer stem cell markers and uses thereof
10/24/2012CN102753193A Light targeting molecules and uses thereof
10/24/2012CN102747096A Gene search vector, random gene mutation control method and application thereof
10/24/2012CN102747044A Porcine pseudorabies virus resisting hybridoma cell line, preparation method thereof, monoclonal antibody and application thereof
10/24/2012CN102747043A Hybridoma cell line 3G1 and anti-alfatoxin B1 monoclonal antibody produced by the same
10/24/2012CN102747042A Hybridoma cell line 10G4 and anti-alfatoxin total (B1, B2, G1 and G2) monoclonal antibody produced by the same
10/24/2012CN102747041A Anti-cyanobacteria recombinant antibody polypeptide, gene and preparation method thereof
10/24/2012CN102747040A Anti-influenza A virus nucleoprotein monoclonal antibody, its preparation and application
10/24/2012CN102747039A Tumor-associated antigen, monoclonal antibody and purpose thereof
10/24/2012CN102746414A Sedimentation method of lipopolysaccharides
10/24/2012CN102746404A Fc variants with altered binding to fcrn
10/24/2012CN102746403A Standard substance universal alternate for aflatoxin detection by using ELISA, preparation method thereof, and ELISA detection method for aflatoxin
10/24/2012CN102746402A Fully-humanized anti-human prolactin receptor single-chain antibody and application thereof
10/24/2012CN102746401A Polypeptide compound for inhibiting angiogenesis and tumor growth
10/24/2012CN102746400A Antibodies against human angiopoietin 2
10/24/2012CN102746399A Anti-Ngf Antibodies And Methods Using Same
10/24/2012CN102746398A Single-chain antibody ZL1 against chicken-derived Newcastle disease virus P protein, preparation method and application thereof
10/24/2012CN102746397A Single-chain antibody ZL2 against chicken-derived Newcastle disease virus P protein, preparation method and application thereof
10/24/2012CN102746382A B-cell epitope peptide of heart fatty acid binding protein (H-FABP), antibody and applications thereof
10/24/2012CN102367436B Anti-human spermine oxidase monoclonal antibody and application thereof
10/24/2012CN102242082B Monoclonal antibody of equine influenza virus nucleoprotein as well as preparation method and application thereof
10/24/2012CN102031245B Monoclonal antibody of avian reticuloendothelial hyperplasia protein gp90 and application thereof
10/24/2012CN101955540B Antibody against fluoroquinolones and application thereof
10/24/2012CN101955539B Immunoassay kit for detecting chloramphenicol and dedicated antibody thereof
10/24/2012CN101812128B Valnemulin artificial antigen and preparation method and application thereof
10/24/2012CN101469329B Compositions and methods for increasing bone mineralization
10/23/2012US8296079 Method for the humanization of antibodies and humanized antibodies thereby obtained
10/23/2012US8293979 Weed controller metabolism proteins, genes, thereof and use of the same
10/23/2012US8293882 Anti-tissue factor antibodies and compositions
10/23/2012US8293874 Recombinant factor X with no glycosylation and method for preparing the same
10/23/2012US8293707 Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for increasing FSH activity
10/23/2012US8293704 Crystalline form of linaclotide
10/23/2012US8293702 Phenolic binding peptides
10/23/2012US8293700 Anti-bacterial composition especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent
10/23/2012US8293491 Purinergic (P2X) receptors in extra-cellular body fluid
10/23/2012US8293483 Method for identifying lineage-related antibodies
1 ... 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 ... 1494